ArticleCureus2025
Anxiety in Hypothyroidism: High Prevalence and Significant Treatment Response in a Rural Nepalese Cohort.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe association between hypothyroidism and anxiety symptoms is well-established. However, there is limited research on this comorbidity in resource-constrained rural settings, such as Nepal, where delayed diagnosis may exacerbate psychiatric burden. This study aimed to assess the prevalence of anxiety among hypothyroid patients in rural Nepal and evaluate the impact of levothyroxine therapy on their symptoms. A key secondary objective was to explore the association between dietary iodine intake and residual post-treatment anxiety.
methodsThis cross-sectional study included 101 hypothyroid patients (mean age: 53.7±1.4 years; 88 (86.3%) female) receiving levothyroxine therapy (median dose: 37.5 mcg (IQR 25-62.5); median duration: 5 years) at a primary health center in Shringa, Nepal. Anxiety severity was assessed using the Hamilton Anxiety Rating Scale (HAM-A) before and after levothyroxine treatment. Dietary iodine intake was also evaluated.
resultsPost-treatment HAM-A scores were significantly lower than pre-treatment scores, with a median decrease of 14 points (P<0.0001; Wilcoxon matched-pairs signed-rank test). Severe anxiety (HAM-A ≥19) was present in 55 (54.5%) patients, moderate in 19 (18.8%) patients, mild in 14 (13.9%) patients, and none in 13 (12.9%) patients. Mean daily salt intake was 10.47±2.57 g, and median daily iodine intake was 340 mcg (IQR 306-408). Dietary iodine intake correlated positively with post-treatment HAM-A scores (
conclusionsAnxiety is highly prevalent among hypothyroid patients in this rural Nepalese setting. Levothyroxine therapy substantially alleviates these anxiety symptoms. For practitioners in rural and remote settings, these findings underscore the importance of managing the psychiatric dimensions of hypothyroidism. Integrating anxiety assessment into routine hypothyroidism care is essential for improving patient outcomes in rural settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.